141 related articles for article (PubMed ID: 22363532)
1. Circulating antinuclear antibodies in patients with pelvic masses are associated with malignancy and decreased survival.
Heegaard NH; West-Nørager M; Tanassi JT; Houen G; Nedergaard L; Høgdall C; Høgdall E
PLoS One; 2012; 7(2):e30997. PubMed ID: 22363532
[TBL] [Abstract][Full Text] [Related]
2. Anti-nuclear antibodies in patients with breast cancer.
Nisihara R; Machoski MCC; Neppel A; Maestri CA; Messias-Reason I; Skare TL
Clin Exp Immunol; 2018 Aug; 193(2):178-182. PubMed ID: 29645079
[TBL] [Abstract][Full Text] [Related]
3. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
[TBL] [Abstract][Full Text] [Related]
4. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
5. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses.
Abdel-Azeez HA; Labib HA; Sharaf SM; Refai AN
Asian Pac J Cancer Prev; 2010; 11(1):111-6. PubMed ID: 20593939
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to carbonic anhydrase in endometriosis: prevalence, specificity, and relationship to clinical and laboratory parameters.
D'Cruz OJ; Wild RA; Haas GG; Reichlin M
Fertil Steril; 1996 Oct; 66(4):547-56. PubMed ID: 8816615
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
[TBL] [Abstract][Full Text] [Related]
9. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma.
Imai H; Nakano Y; Kiyosawa K; Tan EM
Cancer; 1993 Jan; 71(1):26-35. PubMed ID: 8380118
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of antinuclear antibodies in chronic hepatitis B patients].
Şener AG; Aydın N; Ceylan C; Kırdar S
Mikrobiyol Bul; 2018 Oct; 52(4):425-430. PubMed ID: 30522427
[TBL] [Abstract][Full Text] [Related]
11. High Sensitivity Detection of Anti-DFS70 Antibodies by Radioimmunoprecipitation Assay (RIPA).
Seelig CA; Blüthner M; Seelig HP
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390377
[TBL] [Abstract][Full Text] [Related]
12. Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems.
Bizzaro N; Antico A; Platzgummer S; Tonutti E; Bassetti D; Pesente F; Tozzoli R; Tampoia M; Villalta D;
Autoimmun Rev; 2014 Mar; 13(3):292-8. PubMed ID: 24220268
[TBL] [Abstract][Full Text] [Related]
13. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses.
Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H
Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and serological profile of anti-DFS70 positive subjects from a routine ANA cohort.
Carbone T; Pafundi V; Tramontano G; Gilio M; Padula MC; Padula AA; D'Angelo S
Sci Rep; 2019 Feb; 9(1):2177. PubMed ID: 30778125
[TBL] [Abstract][Full Text] [Related]
15. [Antinucleolar antibodies in diagnostics of antiphospholipid syndrome].
Zabek J; Palacz A; Pyka J; Krzewska I
Pol Arch Med Wewn; 2008; 118 Suppl():25-30. PubMed ID: 19562966
[TBL] [Abstract][Full Text] [Related]
16. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
Sebastian W; Roy A; Kini U; Mullick S
Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
[TBL] [Abstract][Full Text] [Related]
17. Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass.
Hogdall EV; Høgdall CK; Tingulstad S; Hagen B; Nustad K; Xu FJ; Bast RC; Jacobs IJ
Int J Cancer; 2000 Nov; 89(6):519-23. PubMed ID: 11102897
[TBL] [Abstract][Full Text] [Related]
18. Anti-DFS70 antibodies detected by immunoblot methods: A reliable tool to confirm the dense fine speckles ANA pattern.
Bizzaro N; Pesente F; Cucchiaro F; Infantino M; Tampoia M; Villalta D; Fabris M; Tonutti E
J Immunol Methods; 2016 Sep; 436():50-3. PubMed ID: 27374867
[TBL] [Abstract][Full Text] [Related]
19. Soluble tumor necrosis factor receptors and CA 125 in serum as markers for epithelial ovarian cancer.
Onsrud M; Shabana A; Austgulen R
Tumour Biol; 1996; 17(2):90-6. PubMed ID: 8658018
[TBL] [Abstract][Full Text] [Related]
20. Significance of anti-nuclear matrix antibodies in patients with in vivo speckled antinuclear antibody staining.
Deng JS; Benedict L; Deng DH; Oddis CV; Fratto J
Arthritis Rheum; 1996 Aug; 39(8):1300-7. PubMed ID: 8702437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
